ArticleCancer medicine2019

Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.

Jwa Hoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.